Singapore, Dec. 22 -- Japan-based Chitose Laboratory Corp. and Fujifilm Biosciences Inc. have announced a new strategic alliance that leverages the strengths of both companies in advancing biopharmaceutical production.

Chitose's expertise in cell line development using the established CHO-MK cells aligns seamlessly with Fujifilm Biosciences' advanced culture media development and manufacturing capabilities. By combining these complementary capabilities, the alliance will help accelerate biopharmaceutical manufacturing processes and support the development of innovative solutions for the industry.

The growth characteristics of CHO-MK cells cultured in the optimised AdaptPD CHO-MK Platform Medium A and AdaptPD CHO-MK Feed 1 have made it p...